Published on September 8, 2006
EXHIBIT
2.2
SRKP
7, Inc.
INSTRUCTION
SHEET FOR INVESTOR
To
be
read in conjunction with the entire attached Securities Purchase Agreement
and
Investor Questionnaire. All capitalized terms used but not defined herein shall
have the meaning assigned to each such term in the Securities Purchase
Agreement.
A. Complete
the following items in the Securities Purchase Agreement and in the Investor
Questionnaire:
1. Provide
the information regarding the Investor requested on the signature page to the
Securities Purchase Agreement and in the Investor Questionnaire. The Securities
Purchase Agreement must be executed by an individual authorized to bind the
Investor.
2. Return
two signed copies Securities Purchase Agreement, Investor Questionnaire and
Registration Rights Agreement together with a check for the purchase price
payable to Law Offices of David L. Kagel, Subscription Escrow Account
to:
WestPark
Capital, Inc.
1900
Avenue of the Stars
Los
Angeles, California 90067
Attn:
Kevin DePrimio
Phone:
(310) 203-2911
Facsimile:
(310) 843-9304
|
-1-
SECURITIES
PURCHASE AGREEMENT
SRKP
7,
Inc.
248
Route
25A, No. 2
East
Setauket, New York 11733
Ladies
and Gentlemen:
The
undersigned investor (the “Investor”), hereby confirms its agreement with you as
follows:
1. This
Securities Purchase Agreement, including Annexes I, II and III, and the exhibits
thereto (the “Agreement”) is made as of May 19, 2006 between SRKP 7, Inc.
(the “Company”) and the Investor with respect to the sale of shares (the
“Shares”) of the Company’s Common Stock (the “Common Stock”).
2. The
Company and the Investor agree that the Investor will purchase from the Company,
and the Company will sell to the Investor, the number of Shares set forth
opposite the Investor’s name on the signature page of this Agreement, at a
purchase price per Share of $0.333, pursuant to the Terms and Conditions for
Purchase of Securities attached hereto as Annex I and incorporated herein by
reference as if fully set forth herein. Unless otherwise requested by the
Investor, certificates representing the Shares will be registered in the
Investor’s name and address as set forth below.
The
next page is the signature page.
-2-
Please
confirm that the foregoing correctly sets forth the agreement between us by
signing in the space provided below for that purpose.
AGREED
AND ACCEPTED:
|
|
COMPANY:
|
SRKP
7, INC.
|
By:_____________________________________
Richard
Rappaport
President
|
|
INVESTOR:
|
name
of investor
|
Number
of Shares:__________________________
|
|
By:______________________________________
Signature
of investor or authorized person
|
|
Its:_______________________________________
Title
of authorized person
|
|
Address:___________________________________
Contact
Name:_______________________________
Facsimile
Number:____________________________
Email
Address:______________________________
|
|
Name
in which share certificates should be registered (if
different):
_________________________________________
|
|
Social
Security
or
Tax I.D. No:_______________________________
|
|
Address
where units should be sent (if different):
__________________________________________
|
-3-
ANNEX
I
TERMS
AND CONDITIONS FOR PURCHASE OF SECURITIES
1. Agreement
to Sell and Purchase the Shares; Subscription Date.
1.1 At
the
Closing (as defined in Section 2), the Company will sell to the Investor,
and the Investor will purchase from the Company, upon the terms and conditions
hereinafter set forth, the Shares.
1.2 The
Company is entering into a substantially similar form of Securities Purchase
Agreement, including these Terms and Conditions, with the other investors listed
along with the Investor (the “Other Investors”). (The Investor and the Other
Investors are hereinafter sometimes collectively referred to as the “Investors,”
and the Securities Purchase Agreement to which these Terms and Conditions are
attached and the securities purchase agreements executed by the Other Investors
are hereinafter sometimes collectively referred to as the “Purchase
Agreements.”)
2. Delivery
of the at Closing.
The
completion of the purchase and sale of the Shares (the “Closing”) shall occur no
later than June 15, 2006, as such date may be extended by the Company and
WestPark Capital, Inc. (the “Closing Date”), at the offices of Troy & Gould,
Professional Corporation, the Company’s counsel. At the Closing, the Company
shall deliver to the Investor (i) one or more stock certificates
representing, in the aggregate, the Shares, each such stock certificate to
be
registered in the name of the Investor or, if so indicated on the signature
page
of the Securities Purchase Agreement, in the name of a nominee designated by
the
Investor. If neither the Investor nor a representative of Investor is present
at
the Closing to take physical delivery of the certificates, then delivery shall
be deemed made at Closing by the transmission of a facsimile of the certificates
to the Investor (or nominee designated by the Investor) followed by delivery
by
a nationally recognized overnight express courier.
The
Company’s obligation to issue the Shares to the Investor shall be subject to the
following conditions, any one or more of which may be waived by the
Company:
(a) receipt
by the Company, or the nominee designated by the Company, as applicable, of
a
certified or official bank check or wire transfer of funds in the full amount
of
the aggregate purchase price for the Shares; and
(b) the
accuracy of the representations and warranties made by the Investors and the
fulfillment of those undertakings of the Investors to be fulfilled prior to
the
Closing.
The
Investor’s obligation to purchase the Shares shall be subject to the Company
acquiring all of the capital stock of Lixte Biotechnology, Inc.
3. Representations,
Warranties and Covenants of the Company.
The
Company hereby represents and warrants to, and covenants with, the Investor,
as
follows:
-1-
3.1 Due
Authorization and Valid Issuance.
The
Company has all requisite power and authority to execute, deliver and perform
its obligations under the Purchase Agreement and the Registration Rights
Agreement referred to in Section 6.1 (collectively, the “Transaction
Documents”), and the Transaction Documents have been duly authorized and validly
executed and delivered by the Company and constitute legal, valid and binding
agreements of the Company enforceable against the Company in accordance with
their terms, except as enforceability may be limited by applicable bankruptcy,
insolvency, reorganization, fraudulent conveyance, moratorium or similar laws
affecting creditors’ and contracting parties’ rights generally and except as
enforceability may be subject to general principles of equity (regardless of
whether such enforceability is considered in a proceeding in equity or at
law).
3.2 Non-Contravention.
The
execution and delivery of the Transaction Documents by the Company, the issuance
and sale of the Shares to be sold by the Company under the Agreements, the
fulfillment of the terms of the Agreements by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby will not
(A) conflict with or constitute a violation of, or default (with the
passage of time or otherwise) under (i) any material bond, debenture, note
or other evidence of indebtedness, or under any material lease, contract,
indenture, mortgage, deed of trust, loan agreement, joint venture or other
agreement or instrument to which the Company is a party or by which the Company
or its properties are bound, (ii) the charter, by-laws or other
organizational documents of the Company, or (iii) any material law,
administrative regulation, ordinance or order of any court or governmental
agency, arbitration panel or authority applicable to the Company or its
properties, or (B) result in the creation or imposition of any lien,
encumbrance, claim, security interest or restriction whatsoever upon any of
the
material properties or assets of the Company or an acceleration of indebtedness
pursuant to any obligation, agreement or condition contained in any material
bond, debenture, note or any other evidence of indebtedness or any material
indenture, mortgage, deed of trust or any other agreement or instrument to
which
the Company is a party or by which it is bound or to which any of the property
or assets of the Company is subject. No consent, approval, authorization or
other order of, or registration, qualification or filing with, any regulatory
body, administrative agency, or other governmental body in the United States
is
required for the execution and delivery of the Transaction Documents by the
Company and the valid issuance and sale of the Shares to be sold by the Company
pursuant to the Agreements, other than such as have been made or obtained,
and
except for any post-closing securities filings or notifications required to
be
made under federal or state securities laws.
3.3 Private
Placement Memorandum.
The Private Placement Memorandum of the Company (the “Memorandum”) delivered to
Investor is true and correct in all material respects as of the date
hereof.
4. Representations,
Warranties and Covenants of the Investor.
4.1 The
Investor represents and warrants to, and covenants with, the Company that:
(i) the Investor is an “accredited investor” as defined in Rule 501 of
Regulation D under the Securities Act of 1933, as amended (the “Securities
Act”), and the Investor is also knowledgeable, sophisticated and experienced in
making, and is qualified to make decisions with respect to, investments in
securities presenting an investment decision like that involved in the purchase
of the Shares, including investments in securities issued by the Company
and
-2-
investments
in comparable companies, and has requested, received, reviewed and considered
all information it deemed relevant in making an informed decision to purchase
the Shares; (ii) the Investor is acquiring the Shares in the ordinary
course of its business and for its own account for investment only and with
no
present intention of distributing any of such Shares or any arrangement or
understanding with any other persons regarding the distribution of such Shares;
(iii) the Investor will not, directly or indirectly, offer, sell, pledge,
transfer or otherwise dispose of (or solicit any offers to buy, purchase or
otherwise acquire or take a pledge of) any of the Shares except in compliance
with the Securities Act, applicable state securities laws and the respective
rules and regulations promulgated thereunder, except that the Investor may
pledge the Shares in connection with a bona fide margin account or other loan
or
financing; (iv) the Investor and the Investor’s representatives, if any,
have been solely responsible for the Investor’s own “due diligence”
investigation of the Company and its management and business, for its own
analysis of the merits and risks of this investment, and for the Investor’s own
analysis of the fairness and desirability of the terms of the investment; and
(v) the Investor has, in connection with its decision to purchase the
Shares, relied only upon the Memorandum and the representations and warranties
of the Company contained herein. The Investor understands that its acquisition
of the Shares has not been registered under the Securities Act or registered
or
qualified under any state securities law in reliance on specific exemptions
therefrom, which exemptions may depend upon, among other things, the bona fide
nature of the Investor’s investment intent as expressed herein. The Investor has
completed or caused to be completed and delivered to the Company the Investor
Questionnaire attached to this Annex I as Exhibit A, which completed
questionnaire is true, correct and complete in all material
respects.
4.2 The
Investor hereby covenants with the Company not to make any sale of the Shares
without complying with the provisions of this Agreement, and the Investor
acknowledges that the certificates evidencing the Shares will be imprinted
with
a legend that prohibits their transfer except in accordance
therewith.
4.3 The
Investor further represents and warrants to, and covenants with, the Company
that (i) the Investor has full right, power, authority and capacity to
enter into this Agreement and to consummate the transactions contemplated hereby
and has taken all necessary action to authorize the execution, delivery and
performance of this Agreement, and (ii) this Agreement constitutes a valid
and binding obligation of the Investor enforceable against the Investor in
accordance with its terms, except as enforceability may be limited by applicable
bankruptcy, insolvency, reorganization, moratorium or similar laws affecting
creditors’ and contracting parties’ rights generally and except as
enforceability may be subject to general principles of equity (regardless of
whether such enforceability is considered in a proceeding in equity or at
law).
4.4 The
Investor understands that nothing in this Agreement or any other materials
presented to the Investor in connection with the purchase and sale of the Shares
constitutes legal, tax or investment advice. The Investor has consulted such
legal, tax and investment advisors as it, in its sole discretion, has deemed
necessary or appropriate in connection with its purchase of the
Shares.
5. Survival
of Representations, Warranties and Agreements.
Notwithstanding any investigation made by any party to this Agreement, all
covenants, agreements, representations
-3-
and
warranties made herein by the Company and the Investor shall survive the
execution of this Agreement, the delivery to the Investor of the Shares being
purchased and the payment therefor.
6. Registration
of the Shares; Compliance with the Securities Act.
6.1 Pursuant
to the Registration Rights Agreement, the Company agrees to file a registration
statement with the Securities and Exchange Commission (“SEC”) no later than 45
days from the closing date of the offering to which this Agreement is a part.
The Company will use its best efforts to cause the registration statement to
be
declared effective by the SEC no later than 120 days from such closing
date.
6.2 Rule 144.
The
Company covenants that it will file the reports required to be filed by it
under
the Securities Act and the Exchange Act and the rules and regulations adopted
by
the SEC thereunder (or, if the Company is not required to file such reports,
it
will, upon the request of the Investor holding Securities purchased hereunder
made after the first anniversary of the Closing Date, make publicly available
such information as necessary to permit sales of the Shares pursuant to
Rule 144 under the Securities Act), and it will take such further action as
the Investor may reasonably request, all to the extent required from time to
time to enable the Investor to sell the Conversion Shares purchased hereunder
without registration under the Securities Act within the limitation of the
exemptions provided by (a) Rule 144 under the Securities Act, as such
rule may be amended from time to time, or (b) any similar rule or
regulation hereafter adopted by the SEC.
7. Notices.
Except
as specifically provided in section 7.1(g), all notices, requests, consents
and other communications hereunder shall be in writing, shall be mailed
(A) if within the United States by first-class registered mail, Express
Mail or nationally recognized overnight express courier, postage prepaid, or
by
facsimile, or (B) if delivered from outside the United States, by
International Federal Express or facsimile, and shall be deemed given
(i) if delivered by first-class registered mail, three business days after
so mailed, (ii) if delivered by Express Mail or a nationally recognized
overnight carrier, one business day after so mailed, (iii) if delivered by
International Federal Express, two business days after so mailed, (iv) if
delivered by facsimile, upon electronic confirmation of receipt and shall be
delivered as addressed as follows:
(a) if
to the
Company, to:
SRKP
7, Inc.
248
Route 25A #2
Setauket,
NY 11733
Attention:
John S. Kovach
Phone:
(631) 751-2882
|
with
a copy to:
|
Troy
& Gould, Professional Corporation
Attn:
David Ficksman
Phone:
(310) 789-1290
Facsimile:
(310) 789-1490
|
-4-
(b) if
to the
Investor, at its address on the signature page hereto, or at such other address
or addresses as may have been furnished to the Company in writing
8. Changes.
This
Agreement may not be modified or amended except pursuant to an instrument in
writing signed by the Company and the Investor.
9. Headings.
The
headings of the various sections of this Agreement have been inserted for
convenience of reference only and shall not be deemed to be part of this
Agreement.
10. Severability.
In case
any provision contained in this Agreement should be invalid, illegal or
unenforceable in any respect, the validity, legality and enforceability of
the
remaining provisions contained herein shall not in any way be affected or
impaired thereby.
11. Governing
Law.
This
Agreement shall be governed by, and construed in accordance with, the internal
laws of the State of California, without giving effect to the principles of
conflicts of law.
12. Entire
Agreement.
This
Agreement constitutes the entire agreement between the parties hereto pertaining
to the subject matter hereof, and any and all other written or oral agreements
relating to such subject matter are expressly cancelled.
13. Finders’
Fees.
Neither
the Company nor the Investor nor any affiliate thereof has incurred any
obligation which will result in the obligation of the other party to pay any
finder’s fee or commission in connection with this transaction, except for fees
payable by the Company to the Placement Agent.
14. Counterparts.
This
Agreement may be executed in two or more counterparts, each of which shall
constitute an original, but all of which, when taken together, shall constitute
but one instrument, and shall become effective when one or more counterparts
have been signed by each party hereto and delivered to the other
parties.
15. Confidential
Information; 8-K Filing.
Investor represents to the Company that, at all times during the Company’s
offering of the Shares, Investor has maintained in confidence all non-public
information regarding the Company received by Investor from the Company or
its
agents, has not traded in the Company’s securities on the basis of any
non-public information and covenants that it will continue to maintain in
confidence such information until such information becomes generally publicly
available, other than through a violation of this provision by Investor or
its
agents. Within four (4) business days after the Closing Date, the Company shall
file a Form 8-K concerning the Agreements and the transactions contemplated
thereby, which Form 8-K shall attach a Form of the Securities Purchase
Agreement and the Registration Rights Agreement as exhibits to such
Form 8-K (the “8-K Filing”). From and after the 8-K Filing, the Company
hereby acknowledges that no Investor shall be in possession of any material
nonpublic information received from the Company or any of its respective
officers, directors, employees or agents, that is not disclosed in the 8-K
Filing.
-5-
16. Successors
and Assigns.
This
Agreement shall inure to the benefit of and be binding upon the successors
and
permitted assigns of the Company and the Investor, including without limitation
and without the need for an express assignment, affiliates of the Investor.
With
respect to transfers that are not made pursuant to the Registration Rights
Agreement, the rights and obligations of an Investor under this Agreement shall
be automatically assigned by the Investor to any transferee of all or any
portion of the Investor’s Shares who is a Permitted Transferee (as defined
below); provided, however, that within two business days prior to the transfer,
(i) the Company is provided notice of the transfer including the name and
address of the transferee and the number of Shares transferred; and
(ii) that such transferee agrees in writing to be bound by the terms of
this Agreement. (For purposes of this Agreement, a “Permitted Transferee” shall
mean any person who (a) is an “accredited investor,” as that term is
defined in Rule 501(a) of Regulation D under the Securities Act and
(b) is a transferee of at least 25% of the Investor’s Shares received in a
transaction permitted under the securities laws of the United States). Upon
any
transfer permitted by the second sentence of this Section 16, the Company
shall be obligated to such transferee to perform all of its covenants under
this
Agreement as if such transferee were an Investor.
-6-
Schedule I
Investors
[Names]
EXHIBIT A
SRKP
7, INC. INVESTOR QUESTIONNAIRE
(ALL
INFORMATION WILL BE TREATED CONFIDENTIALLY)
To: SRKP
7,
Inc.
This
Investor Questionnaire (“Questionnaire”) must be completed by each potential
investor in connection with the offer and sale of shares of the Company’s Common
Stock (the “Shares”). The Shares are being offered and sold by SRKP 7, Inc. (the
“Company”) without registration under the Securities Act of 1933, as amended
(the “Act”), and the securities laws of certain states, in reliance on the
exemptions contained in Section 4(2) of the Act and on Regulation D
promulgated thereunder and in reliance on similar exemptions under applicable
state laws. The Company must determine that a potential investor meets certain
suitability requirements before offering or selling the Shares to such investor.
The purpose of this Questionnaire is to assure the Company that each investor
will meet the applicable suitability requirements. The information supplied
by
the potential investor will be used in determining whether such investor meets
such criteria, and reliance on the private offering exemption from registration
is based in part on the information supplied in this Questionnaire.
This
Questionnaire does not constitute an offer to sell or a solicitation of an
offer
to buy any security. Except as expressly permitted herein, the potential
investor’s answers are to be kept strictly confidential. However, by signing
this Questionnaire the potential investor will be authorizing the Company to
provide a completed copy of this Questionnaire to such parties as the Company
deems appropriate in order to ensure that the offer and sale of the Securities
will not result in a violation of the Act or the securities laws of any state,
and that the potential investor otherwise satisfies the suitability standards
applicable to purchasers of the Securities. All potential investors must answer
all applicable questions and complete, date and sign this Questionnaire. Please
print or type the responses and attach additional sheets of paper if necessary
to complete the answers to any item.
A.
|
BACKGROUND
INFORMATION
|
Name:___________________________________________________________________________________________
Business
Address:__________________________________________________________________________________
(Number
and Street)
_________________________________________________________________________________________________
(City) (State) (Zip
Code)
Telephone
Number:
(___)_____________________________________________________________________________
Residence
Address:_________________________________________________________________________________
(Number
and Street)
________________________________________________________________________________________________
(City) (State) (Zip
Code)
Telephone
Number:
(___)_____________________________________________________________________________
A-1
If
an
individual:
Age: _____
Citizenship: _______________
Where registered to vote: ____________
If
a
corporation, partnership, limited liability company, trust or other
entity:
Type
of
entity: ____________________________________________________________
State
of
formation: __________________
Date of formation: __________________
Social
Security or Taxpayer Identification No. ____________________________________
Send
all
correspondence to (check one): ___
Residence Address ___
Business Address
B.
|
STATUS
AS ACCREDITED INVESTOR
|
The
undersigned is an “accredited investor” as such term is defined in
Regulation D under the Act, as at the time of the sale of the Securities
the undersigned falls within one or more of the following categories (Please
initial one or more, as applicable):1
_____
(1) a
bank as
defined in Section 3(a)(2) of the Act, or a savings and loan association or
other institution as defined in Section 3(a)(5)(A) of the Act whether
acting in its individual or fiduciary capacity; a broker or dealer registered
pursuant to Section 15 of the Securities Exchange Act of 1934; an insurance
company as defined in Section 2(13) of the Act; an investment company
registered under the Investment Corporation Act of 1940 or a business
development company as defined in Section 2(a)(48) of that Act; a Small
Business Investment Corporation licensed by the U.S. Small Business
Administration under Section 301(c) or (d) of the Small Business
Investment Act of 1958; a plan established and maintained by a state, its
political subdivisions, or any agency or instrumentality of a state or its
political subdivisions for the benefit of its employees, if such plan has total
assets in excess of $5,000,000; an employee benefit plan within the meaning
of
the Employee Retirement Income Security Act of 1974 if the investment decision
is made by a plan fiduciary, as defined in Section 3(21) of such Act, which
is either a bank, savings and loan association, insurance company, or registered
investment adviser, or if the employee benefit plan has total assets in excess
of $5,000,000 or, if a self-directed plan, with the investment decisions made
solely by persons that are accredited investors;
_____
(2) a
private
business development company as defined in Section 202(a)(22) of the
Investment Advisers Act of 1940;
_____
(3) an
organization described in Section 501(c)(3) of the Internal Revenue Code of
1986, as amended, corporation, Massachusetts or similar business trust, or
partnership,
1 |
As
used in this Questionnaire, the tem “net worth” means the excess of total
assets over total liabilities. In computing net worth for the purpose
of
subsection (4), the principal residence of the investor must be
valued at
cost, including cost of improvements, or at recently appraised
value by an
institutional lender making a secured loan, net of encumbrances.
In
determining income, the investor should add to the investor’s adjusted
gross income any amounts attributable to tax exempt income received,
losses claimed as a limited partner in any limited partnership,
deductions
claimed for depiction, contributions to an IRA or KEOGH retirement
plan,
alimony payments, and any amount by which income from long-term
capital
gains has been reduced in arriving at adjusted gross
income.
|
A-2
not
formed for the specific purpose of acquiring the Securities offered, with total
assets in excess of $5,000,000;
_____
(4) a
natural
person whose individual net worth, or joint net worth with that person’s spouse,
at the time of such person’s purchase of the Securities exceeds
$1,000,000;
_____
(5) a
natural
person who had an individual income in excess of $200,000, or joint income
with
that person’s spouse in excess of $300,000, in 2003 and 2004 and has a
reasonable expectation of reaching the same income level in 2005;
_____
(6) a
trust,
with total assets in excess of $5,000,000, not formed for the specific purpose
of acquiring the Securities offered, whose purchase is directed by a
sophisticated person as described in Rule 506(b)(2)(ii) of
Regulation D; and
_____
(7) an
entity
in which all of the equity owners are accredited investors (as defined
above).
C.
|
REPRESENTATIONS
|
The
undersigned hereby represents and warrants to the Company as
follows:
1. Any
purchase of the Shares would be solely for the account of the undersigned and
not for the account of any other person or with a view to any resale,
fractionalization, division, or distribution thereof.
2. The
information contained herein is complete and accurate and may be relied upon
by
the Company, and the undersigned will notify the Company immediately of any
material change in any of such information occurring prior to the closing,
if
any, with respect to the purchase of Preferred Shares by the undersigned or
any
co-purchaser.
3. There
are
no suits, pending litigation, or claims against the undersigned that could
materially affect the net worth of the undersigned as reported in this
Questionnaire.
4. In
addition to reviewing the Company’s filings with the Securities and Exchange
Commission and the Memorandum, the undersigned has carefully considered the
potential risks relating to the Corporation and a purchase of the Shares, and
fully understands that the Securities are speculative investments which involve
a high degree of risk of loss of the undersigned’s entire
investment.
IN
WITNESS WHEREOF, the undersigned has executed this Questionnaire this _____
day
of __________, 2006, and declares under oath that it is truthful and
correct.
_____________________________________
Print
Name
|
|
By:____________________________________
Signature
|
|
Title:___________________________________
(required
for any purchaser that is a corporation, partnership, trust or other
entity)
|
A-3